ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,282 | -11.7% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $39,962 | -14.7% | 1,300 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $46,839 | -12.9% | 1,300 | -4.4% | 0.01% | -11.1% |
| Q4 2022 | $53,747 | -0.5% | 1,360 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $54,000 | -6.9% | 1,360 | -0.3% | 0.01% | -9.1% |
| Q2 2022 | $58,000 | +13.7% | 1,364 | +4.9% | 0.01% | +22.2% |
| Q1 2022 | $51,000 | -1.9% | 1,300 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $52,000 | +10.6% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $47,000 | -11.3% | 1,300 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $53,000 | -7.0% | 1,300 | 0.0% | 0.01% | -21.4% |
| Q1 2021 | $57,000 | -12.3% | 1,300 | 0.0% | 0.01% | -17.6% |
| Q4 2020 | $65,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |